Search filters

List of works by John F. Dillon

'Standing Outside the Junkie Door'-service users' experiences of using community pharmacies to access treatment for opioid dependency.

scientific article

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

scientific article

A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland.

scientific article

A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices ⬇️

scientific article published on November 1, 1997

A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

scientific article published on September 2008

A study of the safety of current gastrointestinal endoscopy (EGD).

scientific article published in August 2007

A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes

scientific article

A world without hepatitis C.

scientific article published on May 2014

Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies

scientific article

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study

Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium

scientific article

Application of a discrete choice experiment approach to support the design of a hepatitis C testing service in primary care

scientific article published on 18 December 2018

Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals.

scientific article

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.

scientific article published on 2 September 2013

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

scientific article published on 10 January 2025

Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota.

scientific article

Barrett's esophagus: proton pump inhibitors and chemoprevention I.

scientific article published on September 2011

Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships

scientific article published on 25 October 2018

Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial

scientific article published on 14 December 2018

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

scientific article published on 27 February 2017

Commentary: assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

scientific article published on 01 January 2013

Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B

scientific article published on 01 May 2014

Commentary: real-world triple therapy experience treating hepatitis C virus

scientific article published on March 2014

Commentary: vancomycin or metronidazole in patients with primary sclerosing cholangitis?

scientific article

Contractile response of isolated human hepatic arteries to alpha-adrenoceptor agonists is not impaired in patients with cirrhosis

scientific article published on 01 October 1998

Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

scientific article

Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection.

scientific article

DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy.

scientific article published on 21 June 2017

Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review

scientific article published on 01 April 2020

Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes

scientific article published on 07 February 2018

Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE).

scientific article

Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).

scientific article

Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population

scientific article published on 2 September 2009

Diagnostic laparoscopy and liver disease: experience of 200 cases

scientific article published in June 1994

Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.

scientific article published on 28 November 2017

Does geographic access to primary healthcare influence the detection of hepatitis C?

scientific article published on 03 March 2011

Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles

scientific article published on 19 March 2019

Early diagnosis improves outcomes in hepatitis C.

scientific article

Editorial: sorafenib toxicity, a biomarker of effect?

scientific article

Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD.

scientific article published in January 2018

Endoscopy

scientific article published on December 1995

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)

scientific article published on 24 September 2019

Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care

scientific article published in November 2011

Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006.

scientific article published on 29 June 2010

Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis

scientific article published on 01 March 1995

Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience

scientific article

Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).

scientific article published on 13 December 2017

Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys

scientific article published in 2023

Gamma glutamyl transferase 'To be or not to be' a liver function test?

scientific article published on 20 July 2016

Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK

scientific article published in The Lancet

Guidelines on the management of abnormal liver blood tests

scientific article

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.

scientific article published on 7 October 2014

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

scientific article

Health outcomes following liver function testing in primary care: a retrospective cohort study.

scientific article published on 12 May 2009

Health state utilities associated with attributes of treatments for hepatitis C.

scientific article

Health-state utilities in liver disease: a systematic review.

scientific article published on 18 April 2008

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

article published in 2018

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

scientific article

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

scientific article published on 26 August 2013

High response and re-infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme

scientific article published on 12 December 2018

Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection

article

Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study

scientific article published in January 2010

Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review

scientific article published on 18 May 2019

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

scientific article published on 17 May 2018

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.

scientific article published on 25 March 2018

Implementation of the Lancet Standing Commission on Liver Disease in the UK.

scientific article published on 20 November 2015

Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data

scientific article

Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care

scientific article published on 19 June 2019

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus

scientific article published on 03 September 2019

Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

scientific article published on 09 May 2011

Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?

scientific article published on 28 March 2012

Limited impact of awareness-raising campaigns on hepatitis C testing practices among general practitioners.

scientific article published on 14 May 2017

Liver biopsy bleeding time: an unpredictable event

scientific article published in May 1994

Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.

scientific article published on 13 November 2009

Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2.

scientific article

Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus

scientific article

Minocycline hepatitis.

scientific article published on August 2008

Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.

scientific article published on 17 March 2017

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe".

scientific article published on 25 October 2017

Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population

scientific article published on 18 August 2016

Multidisciplinary managed care networks-Life-saving interventions for hepatitis C patients

scientific article published on 7 November 2016

New horizons in hepatitis B and C in the older adult

scientific article published on 01 January 2019

New metrics for the Lancet Standing Commission on Liver Disease in the UK.

scientific article published on 15 December 2016

Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

scientific article published on 22 April 2013

Paracetamol-related deaths in Scotland, 1994-2000.

scientific article published on October 2002

Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant

scientific article

Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model

scientific article

Platelet basal cytosolic calcium: the influence of plasma factors in cirrhosis

scientific article

Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR.

scientific article published on 10 May 2011

Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts.

scientific article

Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland.

scientific article published on 3 December 2012

Prevalence of Laryngopharyngeal Reflux in a Population With Gastroesophageal Reflux

scientific article published on 01 August 2007

Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease ⬇️

scientific article published on 14 February 2018

Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.

scientific article published on 8 January 2013

Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV t

scientific article published on 08 August 2019

Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland

scientific article published on June 2012

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

scientific article

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.

scientific article published on 22 April 2014

Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication.

scientific article published on 20 May 2016

Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1–6 receiving opioid substitution therapy

scientific article published on 06 February 2019

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

scientific article published on 5 January 2018

Spontaneous bacterial peritonitis prophylaxis in the era of healthcare associated infection

article

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?

scientific article published on 6 November 2014

Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not w ⬇️

scholarly article by Paul Meakin published in September 2014

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles

scientific article

Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.

scientific article

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.

scientific article published on February 2011

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

scientific article

The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination

scientific article published on 01 November 2019

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

scientific article published on 9 July 2018

The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injury

scientific article published on May 2006

The changing spectrum of gastroesophageal reflux disease

scientific article published on 01 June 2002

The correction of autonomic dysfunction in cirrhosis by captopril

scientific article published on 01 February 1997

The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.

scientific article

The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: A systematic review of the literature

scientific article published on 04 June 2015

The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease

scientific article

The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis

scientific article published on 01 September 1995

The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

scientific article published on 19 August 2011

The epidemiology of liver disease in Tayside database: a population-based record-linkage study

scientific article

The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre

scientific article published on 01 October 2010

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS).

scientific article published on 7 April 2017

The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.

scientific article published on 7 March 2016

The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow's injecting drug user population.

scientific article published on 22 October 2010

The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis

scientific article

The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort

scientific article

The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen

scientific article published on 15 November 2017

The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

article

The utility of liver function tests for mortality prediction within one year in primary care using the algorithm for liver function investigations (ALFI).

scientific article

Too many people with viral hepatitis are diagnosed late - with dire consequences

scientific article published on 01 August 2019

Top research priorities in liver and gallbladder disorders in the UK

scientific article published on 07 March 2019

Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes

scientific article published on 26 February 2015

Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide

scientific article published in April 2006

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.

scientific article

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients ⬇️

scientific article published on February 1, 2012

Update on the treatment of hepatitis C genotypes 2-6.

scientific article

Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study

scientific article published on 03 June 2019

Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland

scientific article published on 16 September 2014

Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrettʼs oesophagus

scientific article published on 01 October 2008

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

scientific article published on 04 October 2019

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?

scientific article published on 6 September 2014

Paulina is supported by:

About Paulina

Help